Latest News for: ligand

Edit

Ligand to Report Third Quarter Financial Results on November 9, 2021

Business Wire 26 Oct 2021
EMERYVILLE, Calif.--(BUSINESS WIRE)---- $LGND #earnings--Ligand to Report Third Quarter Financial Results on November 9, 2021 ... .
Edit

Alfa Chemistry Catalysts: Porphyrin Ligands, Phthalocyanine Ligands Are Newly Released

MENA FN 24 Oct 2021
(MENAFN - Market Press Release) October 23, 2021 5.37 am - To meet the increasing demand arising from market and industry, Alfa Chemistry Catalysts announces the release of porphyrin ligands and ... .
Edit

Ligand and CR Double-Crane Enter Collaboration Agreement to Develop an Oral COVID-19 Therapeutic Using Ligand’s ...

Business Wire 21 Oct 2021
EMERYVILLE, Calif.--(BUSINESS WIRE)---- $LGND--Ligand and CR Double-Crane Enter Collaboration Agreement to Develop an Oral COVID-19 Therapeutic using Ligand’s BEPro Technology... .
Edit

Forwardly’s Ligand Innovation Global Completes Production of First LifeAir G1 Prototypes

Nasdaq Globe Newswire 13 Oct 2021
Dayo Olakulehin, CEO of Ligand Innovation Global, Inc., (“Ligand”) a partially owned company and ...
Edit

Thinking about trading options or stock in Mirati Therapeutics, Pfizer, Ligand Pharmaceuticals, Alibaba, or Equinix?

PR Newswire 20 Sep 2021
NEW YORK, Sept. 20, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for MRTX, PFE, LGND, BABA, and EQIX. Click a link below then choose between in-depth options trade idea report or a stock score report ... MRTX ... (Note ... .
Edit

Comserveonline--> Computer-aided Drug Discovery Market by Type (Structure-based Drug Design (SBDD), Ligand-based Drug Design (LBDD), ...

MENA FN 17 Sep 2021
(MENAFN - Comserve) Shibuya-ku, Tokyo, Japan, Japan, Sep 15, 2021, 02.20 /Comserve / -- According to Research Dive analysis, the global computer-aided drug discovery market is estimated to generate ... .
Edit

September Corporate Presentation (Ligand Pharmaceuticals Inc)

Public Technologies 17 Sep 2021
The following presentation contains forward-looking statements by Ligand and its partners that involve risks and uncertainties and reflect Ligand's and it's partners' judgment as of the date of this presentation ... ABOUT LIGAND ... LIGAND ADDS VALUE ... Ligand's technology ... Ligand Pharmaceuticals Inc.
Edit

H.C. Wainwright Investor Conference (Ligand Pharmaceuticals Inc)

Public Technologies 15 Sep 2021
The following presentation contains forward-looking statements by Ligand and its partners that involve risks and uncertainties and reflect Ligand's and it's partners' judgment as of the date of this presentation ... ABOUT LIGAND ... LIGAND ADDS VALUE ... Ligand's technology ... Ligand Pharmaceuticals Inc.
Edit

Probing solution structure of the pentameric ligand-gated ion channel GLIC by small-angle neutron scattering [Biophysics ...

PNAS 09 Sep 2021
Pentameric ligand-gated ion channels undergo subtle conformational cycling ...
Edit

Repligen and Navigo GmbH Announce Launch of Industry-First Protein A Ligand for Purification of pH Sensitive Antibodies

Nasdaq Globe Newswire 09 Sep 2021
Named NGL-Impact® A Hi pH, the new ligand is the first to address antibody aggregation in low pH elution buffers.
Edit

September Investor Roadshow (Ligand Pharmaceuticals Inc)

Public Technologies 09 Sep 2021
The following presentation contains forward-looking statements by Ligand and its partners that involve risks and uncertainties and reflect Ligand's and it's partners' judgment as of the date of this presentation ... ABOUT LIGAND ... LIGAND ADDS VALUE ... Ligand's technology ... Ligand Pharmaceuticals Inc.
Edit

Repligen and Navigo GmbH Announce Launch of Industry-First Protein A Ligand for Purification of pH Sensitive Antibodies (Repligen Corporation)

Public Technologies 09 Sep 2021
Named NGL-Impact® A Hi pH, the new ligand is the first to address antibody aggregation in low pH elution buffers ... Ralf Kuriyel, Repligen Senior Vice President R&D;, said, 'This new best-in-class ligand addresses one of the major pain points in antibody drug purification which is the formation of aggregates during Protein A elution.
×